World's Best Scientists 2026 revealed!
Margarita Sánchez-Beato

Margarita Sánchez-Beato

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
6673
World Ranking
18144
National Ranking
412

Margarita Sánchez-Beato publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Margarita Sánchez-Beato sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 174 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Margarita Sánchez-Beato D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Margarita Sánchez-Beato sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 49 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Margarita Sánchez-Beato is affiliated with the Instituto de Salud Carlos III in Spain. Their research spans multiple disciplines within medicine and the life sciences, with a particular emphasis on oncology, molecular biology, pathology, and immunology. The scientist has contributed extensively to the understanding of lymphoma and related hematological malignancies.

Their work frequently addresses topics such as lymphoma diagnosis and treatment, ubiquitin and proteasome pathways, viral-associated cancers and disorders, chronic lymphocytic leukemia, CAR-T cell therapy, cutaneous lymphoproliferative disorders, and cancer genomics and diagnostics.

Recent publications authored or coauthored by Sánchez-Beato include the following:

  • Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial (2021, Journal for ImmunoTherapy of Cancer)
  • Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers (2021, Blood Advances)
  • Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma (2021, Scientific Reports)
  • Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study (2022, Clinical Cancer Research)
  • Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides: a single-arm, multicentre, phase 2 trial (2022, The Lancet Haematology)

Collaborations are a significant aspect of Sánchez-Beato's research activities. Frequent coauthors include Ismael Fernández-Miranda, Paloma Martín, Mariano Provencio, Miguel Á. Piris, and Juan F. García.

Their research has been published in various journals, with multiple contributions in the following venues:

  • Cancers
  • Blood
  • European Journal of Cancer
  • Hematological Oncology
  • Clinical Cancer Research

The scientist's main fields of study comprise Medicine and Biochemistry, Genetics, and Molecular Biology. Within these fields, Sánchez-Beato focuses on subfields such as Pathology and Forensic Medicine, Oncology, Immunology, Cancer Research, and Molecular Biology. These areas support a research profile strongly oriented towards both clinical and molecular aspects of cancer, particularly lymphomas.

Best Publications

  • Cell cycle deregulation in B-cell lymphomas.

    Margarita Sánchez-Beato;Abel Sánchez-Aguilera;Miguel A. Piris

  • Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

    Ken H Young;Karen Leroy;Michael Boe Møller;Gisele Wb Colleoni

  • p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time.

    M. A. Piris;F. Pezzella;J. C. Martinez-Montero;J. L. Orradre

  • PLCG1 mutations in cutaneous T-cell lymphomas.

    José P. Vaqué;Gonzalo Gómez-López;Verónica Monsálvez;Ignacio Varela

  • Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

    Patricia Algara;Marisol S. Mateo;Margarita Sanchez-Beato;Manuela Mollejo

  • Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

    Manuel M. Morente;Miguel A. Piris;Victor Abraira;Agustin Acevedo

  • Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.

    Francisca I. Camacho;Manuela Mollejo;Maria-Sol Mateo;Patrocinio Algara

  • Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

    Francisca I Camacho;Patrocinio Algara;Antonia Rodriguez;Elena Ruiz-Ballesteros

  • Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

    Margarita Sánchez-Beato;Francisca I. Camacho;Juan C. Martı́nez-Montero;Ana I. Sáez

  • Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor Progression

    Raquel Villuendas;Margarita Sánchez-Beato;Juan C. Martínez;Ana I. Saez

  • Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

    Sánchez-Beato M;Sáez Ai;Martínez-Montero Jc;Sol Mateo M

  • Cancer induction by restriction of oncogene expression to the stem cell compartment

    María Pérez-Caro;César Cobaleda;Inés González-Herrero;Carolina Vicente-Dueñas

  • PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma

    Cristina Gómez-Abad;Helena Pisonero;Carmen Blanco-Aparicio;Giovanna Roncador

  • Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

    Alberto J. Arribas;Yolanda Campos-Martín;Cristina Gómez-Abad;Patrocinio Algara

  • Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.

    Margarita Sánchez-Beato;Esther Sánchez;Joaquín González-Carreró;Manuel Morente

  • The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

    Lorena Di Lisio;Nerea Martinez;Santiago Montes-Moreno;Miguel Piris-Villaespesa

  • Overall Survival in Aggressive B-Cell Lymphomas Is Dependent on the Accumulation of Alterations in p53, p16, and p27

    Margarita Sanchez-Beato;Ana I. Saez;Inmaculada C. Navas;Patrocinio Algara

  • Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas

    Ana Isabel Sáez;Maria Jesús Artiga;Margarita Sánchez-Beato;Lydia Sánchez-Verde

  • Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.

    P. Jares;E. Campo;M. Pinyol;F. Bosch

  • p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways

    Abel Sánchez-Aguilera;Margarita Sánchez-Beato;Juan F. Garcı́a;Ignacio Prieto

Frequent Co-Authors

Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla
Gonzalo Gómez-López
Gonzalo Gómez-López Universidade de Vigo
Juan C. Cigudosa
Juan C. Cigudosa Instituto de Salud Carlos III
Elias Campo
Elias Campo University of Barcelona
Francesc Solé
Francesc Solé Autonomous University of Barcelona
James S. Malter
James S. Malter The University of Texas Southwestern Medical Center
Renato Franco
Renato Franco University of Campania "Luigi Vanvitelli"
Terry D. Oberley
Terry D. Oberley University of Wisconsin–Madison
Isidro Sánchez-García
Isidro Sánchez-García University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry can open many doors in healthcare, research, and emerging technology fields. If you are interested in advancing your career or gaining specialized skills online, there are affordable options. For those interested in leadership, business, and health, the cheapest online mba healthcare management programs offer a practical route to managerial roles in the medical sector.

Another promising area is medical coding and billing. Careers as a certified coding specialist (CCS) are in high demand. If you want to understand the differences between credentials and what they mean for your career, see what it takes to become a certified coding specialist (ccs). Salaries for medical coders are competitive, and you can learn more about how much do medical coders make depending on your qualifications and experience.

Finally, if you are wondering whether to enter medical billing and coding, it is important to weigh all aspects of the profession. Learn about what makes is medical coding a good career to decide if this pathway matches your goals after studying Biology or Biochemistry.

Best Scientists Citing Margarita Sánchez-Beato

Trending Scientists

Recently Published Articles